Keyphrases
Glioblastoma
100%
Neurofibromatosis
88%
Neurofibromatosis Type 1 (NF-1)
61%
Tumor Suppressor Syndrome
44%
Perceived Cancer Risk
44%
Social Self-consciousness
44%
Bodily Self
44%
Epidermal Growth Factor Signaling
44%
Neurofibromatosis Type I
44%
Molecular Profiling
44%
Cediranib
44%
Clinical Considerations
44%
Mutation Status
44%
Antiangiogenic Agents
44%
Clinical Trials
44%
EGFR mutation
44%
Brain Metastases
44%
Diagnostic Considerations
44%
Primary Central Nervous System Lymphoma (PCNSL)
44%
Human Glioma
44%
Non-small Cell Lung Cancer (NSCLC)
44%
Appearance Concerns
44%
High-throughput
44%
Perceived Risk
44%
Emotional Functioning
44%
NF-2
38%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
38%
Epidermal Growth Factor Receptor
33%
Glioma
33%
Brain Cancer
31%
Bodily Self-consciousness
27%
Tumor Cancer
25%
Molecular Pathways
22%
Signaling Axis
22%
Gliomagenesis
22%
AKT/mammalian Target of Rapamycin
22%
Disease Progression
22%
Primary Brain Tumor
22%
Targeted Therapeutics
22%
Mammalian Target of Rapamycin Signaling Pathway
22%
Effective Treatment
22%
Phosphoinositide 3-kinase (PI3K)
22%
Chemotherapy
22%
Patient Selection
22%
Self-esteem
22%
Gene Amplification
22%
Glioma Patients
22%
Genetic Modification
22%
Patient Demographics
21%
Immunocompromised Patients
19%
Medicine and Dentistry
Epidermal Growth Factor Receptor
81%
Glioblastoma
59%
Lung Cancer
44%
Primary Central Nervous System Lymphoma
44%
Ganglioglioma
44%
Brain Metastasis
44%
Patient Population
44%
Diagnosis
44%
Molecular Profiling
44%
Epidermal Growth Factor
44%
Neurofibromatosis
44%
Tumor Suppressor Protein
44%
Diseases
38%
Clinical Trial
37%
Neoplasm
29%
Immunocompromised Patient
22%
Scoring System
22%
Cancer Therapy
22%
Bone Marrow Biopsy
22%
Akt/mTOR Signaling
22%
Physical Examination
22%
Lactate Dehydrogenase
22%
Vitreous
22%
Lumbar Puncture
22%
Brain Biopsy
22%
Human Immunodeficiency Virus
22%
Slit Lamp Microscopy
22%
Magnetic Resonance Imaging
22%
Magnetic Resonance Imaging of Brain
22%
Disease Exacerbation
22%
Phosphoinositide 3-Kinase
22%
Receptor
22%
Intracranial Tumor
22%
Polyethylene Terephthalate
22%
Biopsy Technique
22%
Cerebrospinal Fluid
22%
Cognition
22%
Self Esteem
16%
Gene Mutation
14%
Gene Amplification
14%
Schwannomatosis
11%
Neurofibromatosis Type I
11%
Neurofibromatosis Type II
11%
Methylation
7%
Promoter Region
7%
Targeted Therapy
7%
Patient Selection
7%
Cancer Types
7%
Diagnostic Testing
7%
Cancer
7%